EXMceuticals obtains research & development license for Cannabis-based pharmaceuticals in Portugal
Intel ID : 277853
|
Synopsis
28 OCT 2019
|
|
EXMceuticals, company listed on the Canadian Securities Exchange (CSE), obtained its first cannabis-based pharmaceutical research and development license, enabling it to take an important step in its operations in the European market. The Abreu Advogados law firm team was responsible for the legal advise. Through this license, EXMceuticals establishes its pioneering position in the development of its activities and the conversion of its research work into wellness products and innovative solutions in Portugal. This license facilitates the importation, research and refinement processes of cannabinoids and byproducts in the national territory. |
| Intel ID | 277853 | ||
| Value | ND | ||
| Native Currency | Euro (EUR) | ||
| Date |
 |
||
| Country |  |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legal Advisory
| Parties | Advisor | Type | Notes from Advisors | |||||
|---|---|---|---|---|---|---|---|---|
|
|
- | - |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.